Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × PF06821497 × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Genitourinary 1

Conditions

Prostatic Neoplasms 2 Recurrence 1 Metastatic Castration-Resistant Prostate Cancer 1

Interventions

Peripheral Blood Stem Cell Transplantation 5 Nivolumab 5 Cyclophosphamide 5 fludarabine phosphate 4 Radiotherapy 4 Mycophenolic Acid 4 Carboplatin 4 Gemcitabine 3 Filgrastim 3 Cyclosporine 3 Cisplatin 3 Antilymphocyte Serum 3 cabozantinib 2 cabazitaxel 2 Whole-Body Irradiation 2 Therapeutics 2 Standard of Care 2 Sirolimus 2 Polymerase Chain Reaction 2 Mitomycin 2 Methylprednisolone 2 Methotrexate 2 Itraconazole 2 Goserelin 2 Flow Cytometry 2 Cetuximab 2 Busulfan 2 BCG Vaccine 2 Amplified Fragment Length Polymorphism Analysis 2 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551324 2026-03-04

MEVPRO-1

Pfizer

Phase 3 Recruiting

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡